Affiliated Cancer Hospital and Institute of Guangzhou Medical Univercity
Affiliated Cancer Hospital and Institute of Guangzhou Medical Univercity
Guangzhou, Guangdong, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Multicenter Phase II Randomized Trial of Limertinib Followed by Sintilimab and Chemotherapy vs. Limertinib Followed by Limertinib and Chemotherapy as Neoadjuvant Therapy in Resectable Stage II-IIIB EGFR-Mutant NSCLC | Resectable Non-small Cell Lung Cancer | Not yet recruiting | Phase 2 | 2025-06-26 | NCT07038460 |